longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Quantum-Si

QSI

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -2.38, within the reasonable range, cheaper than 47.74% of the time in the past 5 years, and the industry ranks 30/59, the industry Median -1.82.

-2.38xP/E
$1.07Stock price
$-0.45Earnings per share
-2.38xP/E
Stock price$1.07Earnings per share$-0.45

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-2.44x
Typical range
-3.90x–-1.82x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-347.68x--$47.91B
TEMUSTempus AI
-57.75x1.23%$14.69B
CRLUSCharles River Laboratorie
-59.06x229.32%$14.08B
TXGUS10X Genomics
-156.71x107.32%$11.77B
AVTRUSAvantor
-17.61x142.83%$10.18B
BRKRUSBruker
-92.28x7.71%$9.87B
ABCLUSAbcellera Biologics
-28.71x36.73%$4.73B
ADPTUSAdaptive Biotechnologies
-72.23x39.25%$4.61B
ALMRUSAlamar Biosciences
-47.61x80.55%$2.36B
MRVIUSMaravai LifeSciences
-25.70x65.83%$1.99B
FTREUSFortrea
-22.27x93.77%$1.90B
PSNLUSPersonalis
-16.22x20.05%$1.74B
AZTAUSAzenta
-12.44x180.77%$1.53B
CYRXUSCryoport
-19.42x156.25%$881.29M
DNAUSGinkgo Bioworks
-2.97x35.20%$863.98M
CTKBUSCytek Biosciences
-9.61x33.98%$774.70M
PACBUSPacific Biosc California
-5.61x75.82%$736.67M
OABIUSOmniAb
-16.29x35.96%$721.14M
EVOUSEvotec SE
-2.66x381.02%$607.41M
TKNOUSAlpha Teknova
-28.49x5.80%$477.83M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.